KRRO
Korro BioFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
The post-earnings company update kept the central upside case intact: KRRO-121 is still guided to a second-half 2026 regulatory filing, the AATD program remains on track for a second-quarter 2026 development-candidate nomination, a third GalNAc-conjugated program nomination is targeted for the second half of 2026, and management says the balance sheet can fund operations into the second half of 2028 [#8-K-2026-05-07][#10-Q-2026-05-07].
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -7.9.
What can break
Even with runway improved into the second half of 2028, management says additional capital may still be required over time to fund development, manufacturing, and commercialization efforts [#10-Q-2026-05-07].
Momentum
7
Value
41
Sentiment
69
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $14.00 · Bull $18.00 · Bear $8.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-08 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $19.14
Why
Momentum7 · Δ7d +1.3
Value41 · Δ7d +0.1
Sentiment69 · Δ7d -7.9
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Sentiment · See AI snapshot
Momentum
7
34% active weight
Current posture
7d trendFlat
Δ7d
+1.3
Δ21d
-24.3
Value
41
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.2
Sentiment
69
33% active weight
Current posture
7d trendSoftening
Δ7d
-7.9
Δ21d
-5.0
Why this grade
Composite grade F. Momentum 7.1 / Value 41.1 / Sentiment 69.1
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$186.48M
Beta
2.98
Shares Out
9.42M
P/E (TTM) · Derived
-2.1
P/S (TTM)
10.22
P/FCF (TTM) · Derived
-2.65
Rev YoY
-
EPS YoY
+14.8%
Gross Margin
-
Op Margin
-1282.0%
Net Debt
-$126.1M
Current Ratio
6.71
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology